D. Von Hoff

2.0k citations
24 papers · 1.5k indexed · 1 hit paper · h-index 11

Impact in

  • Oncology top 2%
    • Pancreatic and Hepatic Oncology Research
    • Colorectal Cancer Treatments and Studies
    • Cancer Treatment and Pharmacology
    • Cancer-related Molecular Pathways
    • Cancer Genomics and Diagnostics

Papers in

    • Cancer Treatment and Pharmacology 6
    • Colorectal Cancer Treatments and Studies 4
    • Pancreatic and Hepatic Oncology Research 3
    • Cancer therapeutics and mechanisms 4

D. Von Hoff

23 papers receiving 1.5k citations

Hit Papers

Phase III Trial of Gemcitabine Plus Tipifarnib Compared With Gemcitabine Plus Placebo in Advanced Pancreatic Cancer 2004 · 616 citations
6160+7+14Years since publication200400600

Peers

D. Von Hoff
Comparison fields: 5 of 83
  • Oncology 1.1k
  • Cancer Research 406
  • Pulmonary and Respiratory Medicine 387
  • Molecular Biology 540
  • Genetics 81
Replace Suzanne Russo with:
Suzanne Russo United States
Holger W. Hirte Canada
Nancy T. Sklarin United States
Bunzo Nakata Japan
Lon Smith United States
Jean–Louis Fischel France
Allyson J. Ocean United States
Vicente Guillém Spain
Stephen P. Anthony United States
Carmen Belli Italy
D. Von Hoff relative to Suzanne Russo United States Suzanne Russo's profile →
Citations per field
00.5×1.5×
Suzanne Russo · 1×
Citations per year

Countries citing papers authored by D. Von Hoff

Since Specialization
Citations

This map shows the geographic impact of D. Von Hoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Von Hoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Von Hoff more than expected).

Fields of papers citing papers by D. Von Hoff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Von Hoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Von Hoff. The network helps show where D. Von Hoff may publish in the future.

Co-authors

The 25 scholars most cited alongside D. Von Hoff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with D. Von Hoff Line = papers co-authored together D. Von Hoff links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Phase III Trial of Gemcitabine Plus Tipifarnib Compared With Gemcitabine Plus Placebo in Advanced Pancreatic Cancer
Hit paper breakdown →
2004616
2 2005245
3 1991150
4 1999141
5
DNA sequence amplification in human prostate cancer identified by chromosome microdissection: potential prognostic implications.
199585
6 201173
7
Effect of telomere and telomerase interactive agents on human tumor and normal cell lines.
200071
8 200139
9 201438
10 199734
11 199612
12
New anticancer agents in clinical development.
19959
13
In vitro treatment of autologous bone marrow for neuroblastoma patients with anti GD2 monoclonal antibody and human complement: a pilot study.
19886
14 20096
15 20094
16
Doxorubicin and interferon: rationale and clinical experience.
19853
17 20093
18 19902
19 20112
20 20062

About D. Von Hoff

D. Von Hoff is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Genetics, having authored 24 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (6 papers), Lung Cancer Treatments and Mutations (5 papers), Colorectal Cancer Treatments and Studies (4 papers), Cancer therapeutics and mechanisms (4 papers), Cancer Genomics and Diagnostics (3 papers), Pancreatic and Hepatic Oncology Research (3 papers), Neuroblastoma Research and Treatments (2 papers) and Acute Myeloid Leukemia Research (2 papers). The work is most often cited by research in Oncology (1.1k citations), Cancer Research (406 citations), Pulmonary and Respiratory Medicine (387 citations), Molecular Biology (540 citations) and Genetics (81 citations). D. Von Hoff has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Helmut Oettle, Howard Safran, Helgi van de Velde, Petr Karásek, Patrick Schöffski, Chris Verslype, Walter L. Vervenne, Yves Humblet, Stephanie Post and H Neumann. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Investigational New Drugs, European Journal of Cancer and European Journal of Cancer Supplements.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact